Vigil Neuroscience (VIGL)
(Delayed Data from NSDQ)
$4.40 USD
+0.21 (5.01%)
Updated Jul 11, 2024 04:00 PM ET
After-Market: $4.26 -0.14 (-3.18%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth F Momentum F VGM
Brokerage Reports
Vigil Neuroscience, Inc. [VIGL]
Reports for Purchase
Showing records 1 - 20 ( 46 total )
Company: Vigil Neuroscience, Inc.
Industry: Medical - Biomedical and Genetics
Creative Financing Deal Offers Validation, Extends Runway
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Vigil Neuroscience, Inc.
Industry: Medical - Biomedical and Genetics
Iluzanebart''s Accelerated Approval Depends on the NfL Data - Our Thoughts
Provider: H.C. Wainwright & Co., Inc.
Analyst: FEIN A
Company: Vigil Neuroscience, Inc.
Industry: Medical - Biomedical and Genetics
Company: Vigil Neuroscience, Inc.
Industry: Medical - Biomedical and Genetics
Company: Vigil Neuroscience, Inc.
Industry: Medical - Biomedical and Genetics
Reproducible vMRI and NfL Data Critical for IGNITE 12-Month Data
Provider: H.C. Wainwright & Co., Inc.
Analyst: FEIN A
Company: Vigil Neuroscience, Inc.
Industry: Medical - Biomedical and Genetics
Looking Ahead To IGNITE In 3Q24; All Efforts On Track
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Vigil Neuroscience, Inc.
Industry: Medical - Biomedical and Genetics
Live From AD/PD Lisbon 2024-Microglia Plays a Crucial Role in Amyloid Cascade
Provider: H.C. Wainwright & Co., Inc.
Analyst: FEIN A
Company: Vigil Neuroscience, Inc.
Industry: Medical - Biomedical and Genetics
2024 Sets Up To Be An Important Year For VIGL''''s Pipeline
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Vigil Neuroscience, Inc.
Industry: Medical - Biomedical and Genetics
Company: Vigil Neuroscience, Inc.
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for VIGL 112223
Provider: Stock Traders Daily
Analyst: Research Department
Company: Vigil Neuroscience, Inc.
Industry: Medical - Biomedical and Genetics
Company: Vigil Neuroscience, Inc.
Industry: Medical - Biomedical and Genetics
ILLUMINATEing The IGNITE Readout - Initial Signals There, More Time To Mature
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Vigil Neuroscience, Inc.
Industry: Medical - Biomedical and Genetics
Consistent vMRI and NfL data at 12-month Key for Accelerated Approval
Provider: H.C. Wainwright & Co., Inc.
Analyst: FEIN A
Company: Vigil Neuroscience, Inc.
Industry: Medical - Biomedical and Genetics
Company: Vigil Neuroscience, Inc.
Industry: Medical - Biomedical and Genetics
IGNITE vMRI Data Might Reflect Slowing Down of White Matter Lesions; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: FEIN A
Company: Vigil Neuroscience, Inc.
Industry: Medical - Biomedical and Genetics
Will IGNITE Light A Fire In The Stock? Looking Ahead To 4Q23 Interim Update
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Vigil Neuroscience, Inc.
Industry: Medical - Biomedical and Genetics
Attacking Plaque with a Molecular Glue - Our Insights On VG-3927; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: FEIN A
Company: Vigil Neuroscience, Inc.
Industry: Medical - Biomedical and Genetics
Taking TREM2 Up A Notch With VGL-3927 Advancing [RD Event Takeaways]
Provider: Wedbush Securities Inc.
Analyst: CHICO L